These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 12479267)
1. Retinoic acid-induced growth arrest and differentiation: retinoic acid up-regulates CD32 (Fc gammaRII) expression, the ectopic expression of which retards the cell cycle. Wightman J; Roberson MS; Lamkin TJ; Varvayanis S; Yen A Mol Cancer Ther; 2002 May; 1(7):493-506. PubMed ID: 12479267 [TBL] [Abstract][Full Text] [Related]
2. Transformation-defective polyoma middle T antigen mutants defective in PLCgamma, PI-3, or src kinase activation enhance ERK2 activation and promote retinoic acid-induced, cell differentiation like wild-type middle T. Yen A; Cherington V; Schaffhausen B; Marks K; Varvayanis S Exp Cell Res; 1999 May; 248(2):538-51. PubMed ID: 10222145 [TBL] [Abstract][Full Text] [Related]
3. Retinoic acid induces expression of SLP-76: expression with c-FMS enhances ERK activation and retinoic acid-induced differentiation/G0 arrest of HL-60 cells. Yen A; Varvayanis S; Smith JL; Lamkin TJ Eur J Cell Biol; 2006 Feb; 85(2):117-32. PubMed ID: 16439309 [TBL] [Abstract][Full Text] [Related]
4. Retinoic acid increases amount of phosphorylated RAF; ectopic expression of cFMS reveals that retinoic acid-induced differentiation is more strongly dependent on ERK2 signaling than induced GO arrest is. Yen A; Varvayanis S In Vitro Cell Dev Biol Anim; 2000 Apr; 36(4):249-55. PubMed ID: 10852350 [TBL] [Abstract][Full Text] [Related]
5. Retinoic acid-induced blr1 expression promotes ERK2 activation and cell differentiation in HL-60 cells. Battle TE; Levine RA; Yen A Exp Cell Res; 2000 Feb; 254(2):287-98. PubMed ID: 10640427 [TBL] [Abstract][Full Text] [Related]
6. Polyomavirus small t antigen prevents retinoic acid-induced retinoblastoma protein hypophosphorylation and redirects retinoic acid-induced G0 arrest and differentiation to apoptosis. Yen A; Placanica L; Bloom S; Varvayanis S J Virol; 2001 Jun; 75(11):5302-14. PubMed ID: 11333911 [TBL] [Abstract][Full Text] [Related]
7. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Yen A; Roberson MS; Varvayanis S; Lee AT Cancer Res; 1998 Jul; 58(14):3163-72. PubMed ID: 9679985 [TBL] [Abstract][Full Text] [Related]
8. Retinoic acid selectively activates the ERK2 but not JNK/SAPK or p38 MAP kinases when inducing myeloid differentiation. Yen A; Roberson MS; Varvayanis S In Vitro Cell Dev Biol Anim; 1999 Oct; 35(9):527-32. PubMed ID: 10548434 [TBL] [Abstract][Full Text] [Related]
9. Retinoic acid-induced blr1 expression requires RARalpha, RXR, and MAPK activation and uses ERK2 but not JNK/SAPK to accelerate cell differentiation. Battle TE; Roberson MS; Zhang T; Varvayanis S; Yen A Eur J Cell Biol; 2001 Jan; 80(1):59-67. PubMed ID: 11211936 [TBL] [Abstract][Full Text] [Related]
10. Retinoic acid, bromodeoxyuridine, and the Δ205 mutant polyoma virus middle T antigen regulate expression levels of a common ensemble of proteins associated with early stages of inducing HL-60 leukemic cell differentiation. Yen A; Lin DM; Lamikin TJ; Varvayanis S In Vitro Cell Dev Biol Anim; 2004 Jul; 40(7):216-41. PubMed ID: 27520281 [TBL] [Abstract][Full Text] [Related]
11. Retinoic acid causes MEK-dependent RAF phosphorylation through RARalpha plus RXR activation in HL-60 cells. Hong HY; Varvayanis S; Yen A Differentiation; 2001 Aug; 68(1):55-66. PubMed ID: 11683493 [TBL] [Abstract][Full Text] [Related]
12. Increasing c-FMS (CSF-1 receptor) expression decreases retinoic acid concentration needed to cause cell differentiation and retinoblastoma protein hypophosphorylation. Yen A; Sturgill R; Varvayanis S Cancer Res; 1997 May; 57(10):2020-8. PubMed ID: 9158000 [TBL] [Abstract][Full Text] [Related]
13. Retinoic acid-induced RB (retinoblastoma) hypophosphorylation enhanced by CGP 52411 (4,5-dianilinophthalimide), an EGF family tyrosine kinase receptor inhibitor. Yen A; Soong S Eur J Cell Biol; 1996 Apr; 69(4):327-34. PubMed ID: 8741214 [TBL] [Abstract][Full Text] [Related]
14. Roscovitine enhances All-trans retinoic acid (ATRA)-induced leukemia cell differentiation: Novel effects on signaling molecules for a putative Cdk2 inhibitor. Rashid A; Duan X; Gao F; Yang M; Yen A Cell Signal; 2020 Jul; 71():109555. PubMed ID: 32032659 [TBL] [Abstract][Full Text] [Related]
15. retinoic acid, bromodeoxyuridine, and the Delta 205 mutant polyoma virus middle T antigen regulate expression levels of a common ensemble of proteins associated with early stages of inducing HL-60 leukemic cell differentiation. Yen A; Lin DM; Lamkin TJ; Varvayanis S In Vitro Cell Dev Biol Anim; 2004; 40(7):216-41. PubMed ID: 15638704 [TBL] [Abstract][Full Text] [Related]
16. 6-Formylindolo (3,2-b)carbazole (FICZ) enhances retinoic acid (RA)-induced differentiation of HL-60 myeloblastic leukemia cells. Bunaciu RP; Yen A Mol Cancer; 2013 May; 12():39. PubMed ID: 23656719 [TBL] [Abstract][Full Text] [Related]
17. FMS (CSF-1 receptor) prolongs cell cycle and promotes retinoic acid-induced hypophosphorylation of retinoblastoma protein, G1 arrest, and cell differentiation. Yen A; Sturgill R; Varvayanis S; Chern R Exp Cell Res; 1996 Nov; 229(1):111-25. PubMed ID: 8940255 [TBL] [Abstract][Full Text] [Related]
18. Human myeloblastic leukemia cells (HL-60) express a membrane receptor for estrogen that signals and modulates retinoic acid-induced cell differentiation. Kauss MA; Reiterer G; Bunaciu RP; Yen A Exp Cell Res; 2008 Oct; 314(16):2999-3006. PubMed ID: 18692045 [TBL] [Abstract][Full Text] [Related]
19. All-trans retinoic acid induces p62DOK1 and p56DOK2 expression which enhances induced differentiation and G0 arrest of HL-60 leukemia cells. Lamkin TJ; Chin V; Yen A Am J Hematol; 2006 Aug; 81(8):603-15. PubMed ID: 16823827 [TBL] [Abstract][Full Text] [Related]
20. Retinoic acid-induced CD38 expression in HL-60 myeloblastic leukemia cells regulates cell differentiation or viability depending on expression levels. Lamkin TJ; Chin V; Varvayanis S; Smith JL; Sramkoski RM; Jacobberger JW; Yen A J Cell Biochem; 2006 Apr; 97(6):1328-38. PubMed ID: 16329108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]